We offer valuations focused on science, technology, and development potential, combined with a thorough financial and market analysis. Our services enable informed decisions, maximize value, and capitalize on biopharmaceutical market opportunities.
Valuation & Due Diligence
At SLS Europe, we carry out conclusive valuations and provide expert support for due diligence processes, serving to both buyer and seller perspectives. We leverage our extensive experience and industry insights to deliver reliable assessments that empower our clients to make well-informed strategic decisions.
Due Diligence Support
Our dedicated team assists clients in conducting due diligence processes. We support you in evaluations of assets, technologies, and market dynamics for confident deal navigation.
Company Value Calculation
As part of our valuation and due diligence process, we employ rNPV (risk-adjusted net present value) calculations, taking into account risks inherent in pharmaceutical development, to facilitate strategic decision-making and resource allocation.
Our market analyses provide clients with valuable market intelligence, enabling them to identify key target segments and commercialization opportunities.
Our Service Models
We offer fee-for-service models for defined working packages out of our diverse service portfolio.
Our service on demand is ideal for companies that need support on short notice or within an area beyond their internal expertise.
Our clients have the opportunity of complementing their existing management with our experts over a designated period of time. This cooperation may also be based on a shared risk/benefit model.